When you're looking at a new investment for the first time, the best place to start is the company's last quarterly report. Take, for example, health-care stalwart and reliable dividend stock Johnson & Johnson (NYSE:JNJ). The company reported strong results and raised its guidance for the year; but what were the major growth drivers, and how does its valuation stack up against competitors like Abbott Labs (NYSE:ABT)? In the following video, a segment from The Motley Fool's health-care show Market Checkup, analysts David Williamson and Max Macaluso examine the highs and lows of the company's second quarter.
Max Macaluso and Dave Williamson
Aug 30, 2013 at 7:23PM
Motley Fool Returns
Stock Advisor S&P 500
5 Years 53% 38%
17+ years 341% 95%
Stock Advisor launched in February of 2002. Returns as of 11/17/2019.Join Stock Advisor